Daily Archives: April 5, 2019

Mash Group Plc reports results for the year ending 31 December 2018

Mash Group Plc today announced audited consolidated results for the twelve months ending 31 December 2018.

FINANCIAL HIGHLIGHTS

  • Revenue grew by 110% to EUR 34.5 million, EBIT grew by 221%

AnGes Obtains Conditional Approval in Japan for HGF Gene Therapy to Treat Critical Limb Ischemia

TOKYO, April 05, 2019 (GLOBE NEWSWIRE) — AnGes, Inc., a biopharmaceutical company focused on developing innovative gene-based medicines for treating serious diseases, announced today that they have obtained conditional approval